Cas 459835-97-3,[(2,3-dimethoxy-7-nitro-quinoxalin-5-yl)-methoxycarbonylamino-methyl]-phosphonic acid dimethyl ester

459835-97-3

Post Buying Request

Basic information

Product Name: [(2,3-dimethoxy-7-nitro-quinoxalin-5-yl)-methoxycarbonylamino-methyl]-phosphonic acid dimethyl ester
Synonyms: [(2,3-dimethoxy-7-nitro-quinoxalin-5-yl)-methoxycarbonylamino-methyl]-phosphonic acid dimethyl ester
CAS NO:459835-97-3
Molecular Formula:
Molecular Weight: 430.311
EINECS: N/A
Product Categories: N/A

Chemical Properties

Melting Point: N/A
Boiling Point: N/A
Flash Point: N/A
Appearance: N/A
Density: N/A
Refractive Index: N/A
Storage Temp.: N/A
Solubility: N/A
CAS DataBase Reference: [(2,3-dimethoxy-7-nitro-quinoxalin-5-yl)-methoxycarbonylamino-methyl]-phosphonic acid dimethyl ester(CAS DataBase Reference)
NIST Chemistry Reference: [(2,3-dimethoxy-7-nitro-quinoxalin-5-yl)-methoxycarbonylamino-methyl]-phosphonic acid dimethyl ester(459835-97-3)
EPA Substance Registry System: [(2,3-dimethoxy-7-nitro-quinoxalin-5-yl)-methoxycarbonylamino-methyl]-phosphonic acid dimethyl ester(459835-97-3)

Safety Data

Hazard Codes: N/A
Statements: N/A
Safety Statements: N/A
WGK Germany:
RTECS:
HazardClass: N/A
PackingGroup: N/A
Hazardous Substances Data: 459835-97-3(Hazardous Substances Data)

Suppliers
Usage
Upstream product
Downstream Products
Article

459835-97-3 Suppliers

Recommended suppliers

459835-97-3 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 459835-97-3 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 4,5,9,8,3 and 5 respectively; the second part has 2 digits, 9 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 459835-97:
(8*4)+(7*5)+(6*9)+(5*8)+(4*3)+(3*5)+(2*9)+(1*7)=213
213 % 10 = 3
So 459835-97-3 is a valid CAS Registry Number.

459835-97-3Upstream product

459835-97-3Downstream Products

459835-97-3Relevant academic research and scientific papers

5-Phosphonomethylquinoxalinediones as competitive NMDA receptor antagonists with a preference for the human 1A/2A, rather than 1A/2B receptor composition

Auberson, Yves P,Allgeier, Hans,Bischoff, Serge,Lingenhoehl, Kurt,Moretti, Robert,Schmutz, Markus

, p. 1099 - 1102 (2002)

NMDA antagonists derived from 5-phosphonomethyl-1,4-dihydroquinoxaline-2,3-dione (3a) are potent anticonvulsant agents, and display strong protective effects in the electroshock-induced convulsion assay in mice. Their preference for the human NMDAR 1A/2A over 1A/2B subunit composition was optimized, leading to (1RS,1′S)-PEAQX (9r), which shows a >100-fold selectivity.

Post a RFQ

Cas No.:

Product Name:

Quantity:

Email:

Company name:

Valid Period:

Detailed Requirements:

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

What can I do for you?
Get Best Price

Get Best Price for 459835-97-3